Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
grade D 4.12 -2.83% -0.12
OPTN closed down 2.83 percent on Friday, July 10, 2020, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical OPTN trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Medicine Clinical Medicine Pharmaceutical Organ Systems Disease Inflammation Respiratory Therapy Allergy Glucocorticoids Sinusitis Chronic Rhinosinusitis

Is OPTN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.66
52 Week Low 3.28
Average Volume 574,287
200-Day Moving Average 6.67
50-Day Moving Average 5.12
20-Day Moving Average 5.92
10-Day Moving Average 5.65
Average True Range 0.76
ADX 33.13
+DI 26.36
-DI 26.88
Chandelier Exit (Long, 3 ATRs ) 7.71
Chandelier Exit (Short, 3 ATRs ) 6.21
Upper Bollinger Band 7.82
Lower Bollinger Band 4.02
Percent B (%b) 0.03
BandWidth 64.27
MACD Line -0.17
MACD Signal Line 0.19
MACD Histogram -0.3607
Fundamentals Value
Market Cap 155.58 Million
Num Shares 37.8 Million
EPS -19.61
Price-to-Earnings (P/E) Ratio -0.21
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.80
Resistance 3 (R3) 4.80 4.59 4.68
Resistance 2 (R2) 4.59 4.41 4.58 4.64
Resistance 1 (R1) 4.35 4.31 4.25 4.35 4.61
Pivot Point 4.14 4.14 4.08 4.13 4.14
Support 1 (S1) 3.90 3.96 3.80 3.90 3.63
Support 2 (S2) 3.69 3.86 3.68 3.60
Support 3 (S3) 3.45 3.69 3.56
Support 4 (S4) 3.45